BioSpace

Pharmas Write Big M&A Checks Again as Patent Urgency Seizes C-Suites

For one, interest rates are finally going down, with the Federal Reserve executing its latest cut on December 10. And ...
BioSpace

Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg

Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III ...
BioSpace

Lilly’s Triple Triumph, Prasad’s COVID Error, J&J’s Surprise Voucher, M&A Targets

Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...
BioSpace

Addition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases

Addition joins a growing list of launches this year, following in the footsteps of startups like Crystalys Therapeutics and ...
BioSpace

Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback

Biotech’s slump may finally be over in 2026. In interviews with BioSpace, Zymeworks’ CEO Ken Galbraith and Zai Lab’s ...
BioSpace

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity ...